Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 665-669

  Ayoola, Ephraim A ^a,b   Gadour, Mohammed Oeh ^a  

^a King Fahad Central Hospital   (Saudi Arabia)

^b NONE   (United States)

Author keywords

Cancers; Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Saudi Arabia; Viral hepatitis; Viruses

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHRONIC HEPATITIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; INFECTION RATE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 3042819727     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03334.x     Document Type: Article

References (29)

1. Okuda K. Hepatocellular carcinoma. Recent progress. Hepatology 1992; 15: 948-63.
2. Chen DS. Hepatitis B and C virus infections in hepatocellular carcinoma and their prevention. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer Verlag, 1994; 685-9.
3. Colombo M, Romeo R. Human primary liver cancer and hepatitis C virus in Western countries and Africa. In: Brechot C, ed. Primary Liver Cancer: Etiological and Progressive Factors. XXX: CRC Press, 1994; 49-56.
4. Tsai JF, Jeng JE, Ho MS et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study Br. J. Cancer 1997; 76: 968-74.
5. Benvegnu L, Alberti A. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Res. 2001; 52: 199-207.
6. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in western countries. Hepatogastroenterology 1998; 45: 1206-13.
7. Faleh FZ, Ayoola EA, Arif M et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J. Infect. 1992; 24: 197-206.
8. Arya SC, Ashraf SJ, Parande CM et al. Hepatitis B virus in Gizan, Saudi Arabia. J. Med. Virol. 1985; 17: 267-74.
9. Faleh FZ, Ramia S, Arif M et al. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study. Ann. Trop. Med. Parasitol. 1995; 89: 431-7.
10. Ayoola EA, Al-Mofleh IA, Al-Faleh FZ, Arif MA, Ramia S, Mayet I. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver disease. Hepatogastroenterology 1992; 39: 337-9.
11. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: WB Saunders, 1964; 49-51.
12. Shobokshi OA, Serebour FE, Skakni L, Al-Saffy Y, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J. Med. Virol. 1999; 58: 44-8.
13. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873-4.
14. Olubuyide IO, Aliyu B, Olaleye OA et al. Hepatitis B and C virus and hepatocellular carcinoma. Trans. R. Soc. Trop. Med. Hyg. 1997; 91: 38-41.
15. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62 (Suppl. 1): 8-17.
16. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62 (Suppl. 1): 5-7.
17. Tanioka H, Omagari K, Kato Y et al. Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan: a cross-sectional study of 1019 patients. J. Infect. Chemother. 2002; 8: 64-9.
18. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of antibodies to hepatitis B and C and viral markers in black and white patients with hepatocellular carcinoma in the United States. J. Natl Cancer Inst. 1990; 82: 1038-41.
19. Rapicetta M, Stroffolini T et al. Antibody pattern of HCV infection and hepatocellular carcinoma in Italy: a case control study. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer Verlag, 1994; 703-5.
20. Tanaka S. Type C hepatitis and hepatocellular carcinoma in Japan. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer Verlag, 1994; 713-15, 18.
21. Hadzivannis S, Tabor E, Kaklamani E, Mueller N, Trichopoulos D. A case-control study of hepatitis B and C virus infections in the aetiology of hepatocellular carcinoma. Int. J. Cancer 1995; 60: 627-31.
22. Kubo S, Nishiguchi S, Hirohashi K et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999; 86: 793-8.
23. Marusawa H, Osaki Y, Kimura T et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999; 45: 284-8.
24. Okada S, Sato T, Okusaka T et al. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease. Br. J. Cancer 1998; 77: 2028-31.
25. Yano Y, Yamashita F, Sumie S et al. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Am. J. Gastroenterol. 2002; 97: 156-61.
26. Stroffolini T, Andreone P, Andriulli A et al. Characteristics of hepatocellular carcinoma in Italy. J. Hepatol. 1998; 29: 944-52.
27. el-Hazmi MA. Hepatitis B virus in Saudi Arabia. J. Trop. Med. Hyg. 1989; 92: 56-61.
28. Ayoola EA, Tobaigy MS, Gadour MOEH, Ahmad BS, Hamza MK, Ageel AR. The decline of hepatitis B viral infection in south-western Saudi Arabia. Saudi Med. J. 2003; 24: 447-51.
29. Faleh FZ, Ayoola EA, Al-Jeffry M, Arif M, Al-Rashed RS, Ramia S. Integration of hepatitis B vaccine into the expanded program of immunization: The Saudi Arabian experience. Ann. Saudi Med. 1993; 13: 231-6.